✦ LIBER ✦

Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

✍ Scribed by John W. Eikelboom; Martin O'Donnell; Salim Yusuf; Rafael Diaz; Greg Flaker; Robert Hart; Stefan Hohnloser; Campbell Joyner; Jack Lawrence; Prem Pais; Janice Pogue; David Synhorst; Stuart J. Connolly

Book ID: 116191904
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 208 KB
Volume: 159
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2009.08.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding During Treatment With Aspirin V

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial

✍ Flaker, G. C.; Eikelboom, J. W.; Shestakovska, O.; Connolly, S. J.; Kaatz, S.; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 850 KB

Oral direct thrombin inhibitor AZD0837 f

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB